Cargando…

Low-dose valacyclovir use with preemptive monitoring in kidney transplant recipients with intermediate cytomegalovirus infection risk

Detalles Bibliográficos
Autores principales: VELİOĞLU, Arzu, ALAGÖZ, Selma, BARUTÇU ATAŞ, Dilek, ARIKAN, Hakkı, AŞICIOĞLU, Ebru, AKSU, Burak, SEYAHİ, Nurhan, TUĞLULAR, Serhan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Scientific and Technological Research Council of Turkey (TUBITAK) 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388104/
https://www.ncbi.nlm.nih.gov/pubmed/36326374
http://dx.doi.org/10.55730/1300-0144.5448
_version_ 1785082036879360000
author VELİOĞLU, Arzu
ALAGÖZ, Selma
BARUTÇU ATAŞ, Dilek
ARIKAN, Hakkı
AŞICIOĞLU, Ebru
AKSU, Burak
SEYAHİ, Nurhan
TUĞLULAR, Serhan
author_facet VELİOĞLU, Arzu
ALAGÖZ, Selma
BARUTÇU ATAŞ, Dilek
ARIKAN, Hakkı
AŞICIOĞLU, Ebru
AKSU, Burak
SEYAHİ, Nurhan
TUĞLULAR, Serhan
author_sort VELİOĞLU, Arzu
collection PubMed
description
format Online
Article
Text
id pubmed-10388104
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Scientific and Technological Research Council of Turkey (TUBITAK)
record_format MEDLINE/PubMed
spelling pubmed-103881042023-08-01 Low-dose valacyclovir use with preemptive monitoring in kidney transplant recipients with intermediate cytomegalovirus infection risk VELİOĞLU, Arzu ALAGÖZ, Selma BARUTÇU ATAŞ, Dilek ARIKAN, Hakkı AŞICIOĞLU, Ebru AKSU, Burak SEYAHİ, Nurhan TUĞLULAR, Serhan Turk J Med Sci Letter to the Editor Scientific and Technological Research Council of Turkey (TUBITAK) 2022-04-19 /pmc/articles/PMC10388104/ /pubmed/36326374 http://dx.doi.org/10.55730/1300-0144.5448 Text en © TÜBİTAK https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License.
spellingShingle Letter to the Editor
VELİOĞLU, Arzu
ALAGÖZ, Selma
BARUTÇU ATAŞ, Dilek
ARIKAN, Hakkı
AŞICIOĞLU, Ebru
AKSU, Burak
SEYAHİ, Nurhan
TUĞLULAR, Serhan
Low-dose valacyclovir use with preemptive monitoring in kidney transplant recipients with intermediate cytomegalovirus infection risk
title Low-dose valacyclovir use with preemptive monitoring in kidney transplant recipients with intermediate cytomegalovirus infection risk
title_full Low-dose valacyclovir use with preemptive monitoring in kidney transplant recipients with intermediate cytomegalovirus infection risk
title_fullStr Low-dose valacyclovir use with preemptive monitoring in kidney transplant recipients with intermediate cytomegalovirus infection risk
title_full_unstemmed Low-dose valacyclovir use with preemptive monitoring in kidney transplant recipients with intermediate cytomegalovirus infection risk
title_short Low-dose valacyclovir use with preemptive monitoring in kidney transplant recipients with intermediate cytomegalovirus infection risk
title_sort low-dose valacyclovir use with preemptive monitoring in kidney transplant recipients with intermediate cytomegalovirus infection risk
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388104/
https://www.ncbi.nlm.nih.gov/pubmed/36326374
http://dx.doi.org/10.55730/1300-0144.5448
work_keys_str_mv AT veliogluarzu lowdosevalacyclovirusewithpreemptivemonitoringinkidneytransplantrecipientswithintermediatecytomegalovirusinfectionrisk
AT alagozselma lowdosevalacyclovirusewithpreemptivemonitoringinkidneytransplantrecipientswithintermediatecytomegalovirusinfectionrisk
AT barutcuatasdilek lowdosevalacyclovirusewithpreemptivemonitoringinkidneytransplantrecipientswithintermediatecytomegalovirusinfectionrisk
AT arikanhakkı lowdosevalacyclovirusewithpreemptivemonitoringinkidneytransplantrecipientswithintermediatecytomegalovirusinfectionrisk
AT asiciogluebru lowdosevalacyclovirusewithpreemptivemonitoringinkidneytransplantrecipientswithintermediatecytomegalovirusinfectionrisk
AT aksuburak lowdosevalacyclovirusewithpreemptivemonitoringinkidneytransplantrecipientswithintermediatecytomegalovirusinfectionrisk
AT seyahinurhan lowdosevalacyclovirusewithpreemptivemonitoringinkidneytransplantrecipientswithintermediatecytomegalovirusinfectionrisk
AT tuglularserhan lowdosevalacyclovirusewithpreemptivemonitoringinkidneytransplantrecipientswithintermediatecytomegalovirusinfectionrisk